Role of Immunoglobulin in Male Infertility

Not Applicable

Recruiting

• Conditions: Male Subfertility
• Interventions: Combination Product: IVIG

• Registration Number: NCT06423989
• Lead Sponsor: Dr Salma kafeel Qureshi

Brief Summary

to investigate the role of IVIG in male infertility and to determine its benefits in term of semen parameters and assisted reproduction outcome

Detailed Description

Not available

Study Timeline

• Study Start: 2023-04-01
• Study First Submitted: 2024-04-17
• Status Verified: 2024-05
• Study First Submitted QC: 2024-05-16
• Last Update Submitted: 2024-05-16
• Study First Posted: 2024-05-21
• Last Update Posted: 2024-05-21
• Primary Completion: 2024-06-01
• Study Completion: 2024-12-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Male
• Target Recruitment: 50

Inclusion Criteria

• male patients

Exclusion Criteria

• female

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
male fertility	IVIG	-

Primary Outcome Measures

Name	Time	Method
Semen parameters percentage improvement	6 month	Sperm concentration/ml
Sperm morphology	6 month	Percentage of normal sperm
Sperm motility	6 month	Percentage active motile sperm

Secondary Outcome Measures

Name	Time	Method
Assisted Reproduction outcome measure	12 months	Percentage of fertilized

Trial Locations

Locations (1)

SKMC; 🇵🇰 Islamabad, Capital, Pakistan